Foley & Lardner LLP looks beyond the law to focus on the constantly evolving demands facing our clients and their industries. With over 1,100 lawyers in 24 offices across the United States, Mexico, Europe and Asia, Foley approaches client service by first understanding our clients’ priorities, objectives and challenges. We work hard to understand our clients’ issues and forge long-term relationships with them to help achieve successful outcomes and solve their legal issues through practical business advice and cutting-edge legal insight. Our clients view us as trusted business advisors because we understand that great legal service is only valuable if it is relevant, practical and beneficial to their businesses.
The Federal Circuit has denied the petition for rehearing en banc in Ariosa Diagnostics, Inc. v. Sequenom, Inc., despite the filing of twelve amicus briefs in support of the petition.
United StatesFood, Drugs, Healthcare, Life Sciences
The Federal Circuit has denied the petition for rehearing en
banc in Ariosa Diagnostics, Inc. v. Sequenom, Inc.,
despite the filing of twelve amicus briefs in support of
the petition, including briefs filed by Biotechnology Industry
Organization and Pharmaceutical Research and Manufacturers of
America, numerous innovator companies in the diagnostic space, and
law professors. The en banc order was accompanied by concurring opinions
authored by Judge Lourie (joined by Judge Moore) and Judge Dyk, and
a dissenting opinion authored by Judge Newman.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.